Eone Diagnomics Genome Center Co.Ltd. (KOSDAQ:A245620) signed a definitive agreement to acquire 49.9% stake in Cns Healthcare, Ltd from Kyungsook Im, Soonbae Cha and Yoonsoon Han for KRW 19.7 billion on September 4, 2018. Eone Diagnomics Genome Center will acquire Cns Healthcare 0.02 million shares. Kyungsook Im, Soonbae Cha and Yoonsoon Han will sell 8358, 8400 and 4200 shares respectively for KRW 7.9 billion, KRW 8 billion and KRW 4 billion respectively. The consideration is paid on signing of definitive agreement. Cns Healthcare, Ltd reported total assets of KRW 24.5 billion and net assets of KRW 10.7 billion as of December 31, 2017 and revenues of KRW 46.5 billion and net profit of KRW 5.1 billion for the year ended December 31, 2017. The transaction is resolved by Board of Eone Diagnomics Genome Center on September 4, 2018. The transaction is expected to close on September 4, 2018. BDO Daejoo LLC acted as external rating institution in the transaction.